Outbreak of Ceftazidime-Resistant Klebsiella pneumoniae in a Pediatric Hospital in Warsaw, Poland: Clonal Spread of the TEM-47 Extended-Spectrum β-Lactamase (ESBL)-Producing Strain and Transfer of a Plasmid Carrying the SHV-5-Like ESBL-Encoding Gene
暂无分享,去创建一个
[1] W. Hryniewicz,et al. Ceftazidime-Resistant EnterobacteriaceaeIsolates from Three Polish Hospitals: Identification of Three Novel TEM- and SHV-5-Type Extended-Spectrum β-Lactamases , 1998, Antimicrobial Agents and Chemotherapy.
[2] F. Kayser,et al. Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12 , 1997, Antimicrobial agents and chemotherapy.
[3] M. Struelens,et al. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae , 1996, Journal of clinical microbiology.
[4] L. Rice,et al. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] R. Labia,et al. Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France , 1996, Antimicrobial agents and chemotherapy.
[6] I. Stemplinger,et al. Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase , 1996, Antimicrobial agents and chemotherapy.
[7] A. Péchinot,et al. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae , 1996, Journal of clinical microbiology.
[8] T. Pitt,et al. Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. , 1995, The Journal of hospital infection.
[9] D. Livermore. beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.
[10] R. Venezia,et al. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] K. Bush,et al. SHV-7, a Novel Cefotaxime-Hydrolyzing β-Lactamase, Identified in Escherichia coli Isolates from Hospitalized Nursing Home Patients , 1995 .
[12] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[13] Willem,et al. Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains , 1995, Journal of clinical microbiology.
[14] K. Bush,et al. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients , 1995, Antimicrobial agents and chemotherapy.
[15] R. Gaynes,et al. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. , 1994, The Journal of infectious diseases.
[16] D. Sirot,et al. Sequences of CAZ-3 and CTX-2 extended-spectrum beta-lactamase genes , 1994, Antimicrobial Agents and Chemotherapy.
[17] K. Bush,et al. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate , 1994, Antimicrobial Agents and Chemotherapy.
[18] P. Hawkey,et al. Convergent evolution of TEM-26, a β-lactamase with extended-spectrum activity , 1994 .
[19] G. Bourg,et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital , 1994, Journal of clinical microbiology.
[20] K. Bush,et al. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae , 1994, Antimicrobial Agents and Chemotherapy.
[21] M. Struelens,et al. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. , 1993, The American journal of medicine.
[22] K S Meyer,et al. Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins , 1993, Annals of Internal Medicine.
[23] J. Quinn,et al. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences , 1993, Antimicrobial Agents and Chemotherapy.
[24] D. Livermore,et al. Survey of the prevalence of beta-lactamases amongst 1000 gram-negative bacilli isolated consecutively at the Royal London Hospital. , 1992, The Journal of antimicrobial chemotherapy.
[25] J. Heritage,et al. Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase , 1992, Antimicrobial Agents and Chemotherapy.
[26] C. Soussy,et al. Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France , 1992, Antimicrobial Agents and Chemotherapy.
[27] A. Darfeuille‐Michaud,et al. Translocation of antibiotic resistance determinants including an extended-spectrum beta-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli , 1991, Antimicrobial Agents and Chemotherapy.
[28] J M Ghuysen,et al. A standard numbering scheme for the class A beta-lactamases. , 1991, The Biochemical journal.
[29] L. Gutmann,et al. Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid , 1990, Antimicrobial Agents and Chemotherapy.
[30] G. Papanicolaou,et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility , 1990, Antimicrobial Agents and Chemotherapy.
[31] I. Phillips,et al. Importation of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom , 1990 .
[32] R. Cluzel,et al. Multiplicity of TEM-derived beta-lactamases from Klebsiella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids , 1989, Antimicrobial Agents and Chemotherapy.
[33] V. Jarlier,et al. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. , 1988, Reviews of infectious diseases.
[34] R. Cluzel,et al. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins , 1988, Antimicrobial Agents and Chemotherapy.
[35] R. Labia,et al. Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1). , 1988, The Biochemical journal.
[36] J. Carlet,et al. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors , 1988, Antimicrobial Agents and Chemotherapy.
[37] R. Cluzel,et al. Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. , 1987, The Journal of antimicrobial chemotherapy.
[38] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[39] H. Birnboim,et al. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. , 1979, Nucleic acids research.
[40] J. Sutcliffe,et al. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[41] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Harris,et al. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.
[43] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[44] A. Medeiros,et al. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics , 1997 .
[45] R. Spencer,et al. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. , 1990, Plasmid.
[46] S. Highlander,et al. Mutational and physiological analyses of plasmid pT181 functions expressing incompatibility. , 1990, Plasmid.
[47] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[48] H. Birnboim,et al. A RAPID ALKALINE EXTRACTION PROCEDURE FOR SCREENING RECOMBINANT DNA , 1979 .